Vaccine News and Research

Latest Vaccine News and Research

Recycling tubular endosomes are associated with effective delivery of mRNA-based therapeutics, study finds

A recent study recently demonstrates the endosomal transport of nanoparticle-based formulations for the effective delivery of mRNA-based therapeutics.

14 Dec 2021

Duke Human Vaccine Institute secures federal contract for advancing investigational vaccines

The National Institute of Allergy and Infectious Diseases awarded researchers at the Duke Human Vaccine Institute a contract that enables it to compete for projects advancing investigational vaccines to production for use in early clinical trials.

14 Dec 2021

Temporary suspension of 15-minute observation period after vaccination to accelerate booster program

The 15 minute observation period following a vaccination with Pfizer or Moderna will be temporarily suspended as part of new measures to speed up the booster rollout as part of our emergency response to the rapid spread of the Omicron variant.

14 Dec 2021

WHO and UNICEF warn about the lack of basic water services in health care facilities

Around 1.8 billion people are at heightened risk of COVID-19 and other diseases because they use or work in health care facilities without basic water services, warn WHO and UNICEF.

14 Dec 2021

England's Chief Medical Officer calls on the public to get booster vaccination

Chief Medical Officer for England Professor Chris Whitty will call on the public to get a booster vaccination, in a nationwide advertising campaign launching today (Tuesday 14 December) to further galvanize the booster program.

14 Dec 2021

HM Treasury announces additional funding for devolved administrations to tackle Covid-19

While the devolved administrations are well-funded to continue their response to Covid-19, and have their own reserves and contingency funds, any additional in-year Barnett funding will not be confirmed until early 2022 through the Supplementary Estimates process.

14 Dec 2021

Vaccinated seropositive individuals are able to induce high anti-spike SIgA responses

Results of a new study show that the induction of anti-SARSCoV-2 spike saliva SIgA antibodies after vaccination is independent of the gender or type of vaccine received.

14 Dec 2021

Changes in trajectory of long COVID symptoms before vaccination

A new preprint describes the results of a study examining this aspect of the disease.

14 Dec 2021

Assay for the identification of SARS-CoV-2 Spike reactive T and B cells

An interesting new paper presents a new assay for B and T lymphocytes in individuals infected with SARS-CoV-2.

14 Dec 2021

Evaluating the exclusion of unvaccinated people in the prevention of SARS-CoV-2 transmission

New study results suggest that the numbers needed to exclude model and baseline infection risk could be key indicators of the drawbacks and benefits of vaccine mandates and vaccine passports.

14 Dec 2021

Risk of SARS-CoV-2 reinfection in children compared to adults

The current study aimed to explore the rate and risk of SARS-CoV-2 reinfections in children.

14 Dec 2021

New mRNA vaccine platform provides stronger protection against SARS-CoV-2 delta variant

A group of researchers from various institutions developed a nucleoside-modified mRNA vaccine that encodes the SARS-CoV-2 N protein (mRNA-N) and is formulated in lipid nanoparticles for this investigation (LNP).

14 Dec 2021

Machine learning method for determining impact of mutations in the SARS-CoV-2 RBD on binding and antibody escape

Deep mutational learning (DML) is a technique developed by researchers from multiple institutions that combines experimental yeast display screening of RBD mutagenesis libraries with deep sequencing and machine learning.

14 Dec 2021

Characteristics of SARS-CoV-2 breakthrough infections tracked in large US study

Researchers from Microsoft Corporation, Fred Hutch Cancer Research Center, and the University of Washington recently published a report on the preprint server medRxiv* wherein they studied a de-identified cohort from the United States medical claims records from Change Healthcare to estimate the risk of hospitalization and death, by vaccine type and by previous SARS-CoV2 infection, among SARS-CoV-2 breakthrough infections in fully vaccinated individuals.

14 Dec 2021

Trial in sub-Saharan Africa evaluates the efficacy of COVID-19 vaccine in people living with HIV

A highly anticipated clinical trial in eight sub-Saharan countries is the first to specifically evaluate the efficacy of a COVID-19 vaccine in people living with HIV, including those with poorly controlled infections.

13 Dec 2021

Omicron variant may strike double vaccinated

Largely, scientists are skeptical that the Omicron variant can infect vaccinated individuals. However, a new study published on the medRxiv* preprint server has conducted neutralization assays using an Omicron isolate obtained from patients residing in the United Kingdom.

13 Dec 2021

COVID-19 vaccines offer protection for multiple myeloma patients, but lesser than other cancer survivors

For patients with the blood cancer multiple myeloma, vaccination against COVID-19 provides some protection against coronavirus infection but to a far lower degree than the general population of cancer survivors, a new study by Dana-Farber Cancer Institute investigators shows.

13 Dec 2021

Vaccine News and Research

Latest Vaccine News and Research

Recycling tubular endosomes are associated with effective delivery of mRNA-based therapeutics, study finds

Duke Human Vaccine Institute secures federal contract for advancing investigational vaccines

Temporary suspension of 15-minute observation period after vaccination to accelerate booster program

WHO and UNICEF warn about the lack of basic water services in health care facilities

England's Chief Medical Officer calls on the public to get booster vaccination

HM Treasury announces additional funding for devolved administrations to tackle Covid-19

Vaccinated seropositive individuals are able to induce high anti-spike SIgA responses

Changes in trajectory of long COVID symptoms before vaccination

Assay for the identification of SARS-CoV-2 Spike reactive T and B cells

Evaluating the exclusion of unvaccinated people in the prevention of SARS-CoV-2 transmission

Risk of SARS-CoV-2 reinfection in children compared to adults

New mRNA vaccine platform provides stronger protection against SARS-CoV-2 delta variant

Machine learning method for determining impact of mutations in the SARS-CoV-2 RBD on binding and antibody escape

Characteristics of SARS-CoV-2 breakthrough infections tracked in large US study

Trial in sub-Saharan Africa evaluates the efficacy of COVID-19 vaccine in people living with HIV

Omicron variant may strike double vaccinated

COVID-19 vaccines offer protection for multiple myeloma patients, but lesser than other cancer survivors

Determination of the effectiveness of COVID-19 vaccination using T cell receptor repertoire

Characteristics of vaccine breakthroughs in fully vaccinated individuals in France with delta variant

Novel assay using finger-prick samples provides COVID-19 vaccine efficacy data

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Vaccine News and Research

Latest Vaccine News and Research

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in